BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 16240900)

  • 1. Serum 25(OH)-vitamin D levels and bone metabolism in patients on maintenance hemodialysis.
    Mucsi I; Almási C; Deák G; Marton A; Ambrus C; Berta K; Lakatos P; Szabó A; Horváth C
    Clin Nephrol; 2005 Oct; 64(4):288-94. PubMed ID: 16240900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No Associations of 25-Hydroxycholecalciferol and Parathyroid Hormone Concentrations with Calcaneal Bone Characteristics in Community-Dwelling Elderly Subjects: A Cross-Sectional Study.
    Jungert A; Neuhäuser-Berthold M
    J Nutr Health Aging; 2017; 21(6):733-742. PubMed ID: 28537341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for persistent vitamin D 1-alpha-hydroxylation in hemodialysis patients: evolution of serum 1,25-dihydroxycholecalciferol after 6 months of 25-hydroxycholecalciferol treatment.
    Jean G; Terrat JC; Vanel T; Hurot JM; Lorriaux C; Mayor B; Chazot C
    Nephron Clin Pract; 2008; 110(1):c58-65. PubMed ID: 18724068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between vitamin D status, parathyroid hormone levels and bone mineral density in patients with chronic kidney disease stages 3 and 4.
    Stavroulopoulos A; Porter CJ; Roe SD; Hosking DJ; Cassidy MJ
    Nephrology (Carlton); 2008 Feb; 13(1):63-7. PubMed ID: 18199106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of bone mineral density in renal transplantation recipients.
    Unal A; Kocyigit I; Sipahioglu MH; Tokgoz B; Kavuncuoglu F; Oymak O; Utas C
    Transplant Proc; 2010 Nov; 42(9):3550-3. PubMed ID: 21094813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioavailable vitamin D levels are reduced and correlate with bone mineral density and markers of mineral metabolism in adults with nephrotic syndrome.
    Aggarwal A; Yadav AK; Ramachandran R; Kumar V; Kumar V; Sachdeva N; Khandelwal N; Jha V
    Nephrology (Carlton); 2016 Jun; 21(6):483-9. PubMed ID: 26428957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nutritional markers, not markers of bone turnover, are related predictors of bone mineral density in chronic peritoneal dialysis patients.
    Jeong JU; Lee HK; Kim YJ; Kim JS; Kang SS; Kim SB
    Clin Nephrol; 2010 Nov; 74(5):336-42. PubMed ID: 20979940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Circulating bone turnover markers and their relationships in hemodialysis patients with vitamin D deficiency].
    Kulicki P; Żebrowski P; Sokalski A; Klatko W; Birecka M; Mieczkowski M; Niemczyk S; Małyszko J; Matuszkiewicz-Rowińska J
    Wiad Lek; 2019; 72(11 cz 2):2202-2209. PubMed ID: 31860837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of immune status in relation to vitamin D levels in children on regular hemodialysis.
    Youssef DM; Elshal AS; Abo Elazem AA
    Saudi J Kidney Dis Transpl; 2012 Mar; 23(2):267-73. PubMed ID: 22382217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dietary vitamin D intake is not associated with 25-hydroxyvitamin D3 or parathyroid hormone in elderly subjects, whereas the calcium-to-phosphate ratio affects parathyroid hormone.
    Jungert A; Neuhäuser-Berthold M
    Nutr Res; 2013 Aug; 33(8):661-7. PubMed ID: 23890356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteoprotegerin and bone mineral density in hemodiafiltration patients.
    Crisafulli A; Romeo A; Floccari F; Aloisi E; Atteritano M; Cincotta M; Aloisi C; Pizzoleo MA; Ruello A; Artemisia A; Valenti A; Frisina N; Teti D; Buemi M
    Ren Fail; 2005; 27(5):531-9. PubMed ID: 16152990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association among serum fetuin-A level, coronary artery calcification, and bone mineral densitometry in maintenance hemodialysis patients.
    Kirkpantur A; Altun B; Hazirolan T; Akata D; Arici M; Kirazli S; Turgan C
    Artif Organs; 2009 Oct; 33(10):844-54. PubMed ID: 19681840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Daily oral 25-hydroxycholecalciferol supplementation for vitamin D deficiency in haemodialysis patients: effects on mineral metabolism and bone markers.
    Jean G; Terrat JC; Vanel T; Hurot JM; Lorriaux C; Mayor B; Chazot C
    Nephrol Dial Transplant; 2008 Nov; 23(11):3670-6. PubMed ID: 18579534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D status and sex hormone binding globulin: determinants of bone turnover and bone mineral density in elderly women.
    Ooms ME; Lips P; Roos JC; van der Vijgh WJ; Popp-Snijders C; Bezemer PD; Bouter LM
    J Bone Miner Res; 1995 Aug; 10(8):1177-84. PubMed ID: 8585420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Profile of chronic kidney disease related-mineral bone disorders in newly diagnosed advanced predialysis diabetic kidney disease patients: A hospital based cross-sectional study.
    Ray S; Beatrice AM; Ghosh A; Pramanik S; Bhattacharjee R; Ghosh S; Raychaudhury A; Mukhopadhyay S; Chowdhury S
    Diabetes Metab Syndr; 2017 Dec; 11 Suppl 2():S931-S937. PubMed ID: 28728874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone metabolism, density, and geometry in postmenopausal women with vitamin D insufficiency: a cross-sectional comparison of the effects of elevated parathyroid levels.
    Rødbro LL; Bislev LS; Sikjær T; Rejnmark L
    Osteoporos Int; 2018 Oct; 29(10):2211-2218. PubMed ID: 29955908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of serum 25-hydroxy vitamin D levels on Helicobacter Pylori Infections in patients with end-stage renal failure on regular hemodialysis.
    Nasri H; Baradaran A
    Saudi J Kidney Dis Transpl; 2007 Jun; 18(2):215-9. PubMed ID: 17496397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone Quality Assessment as Measured by Trabecular Bone Score in Patients With End-Stage Renal Disease on Dialysis.
    Yavropoulou MP; Vaios V; Pikilidou M; Chryssogonidis I; Sachinidou M; Tournis S; Makris K; Kotsa K; Daniilidis M; Haritanti A; Liakopoulos V
    J Clin Densitom; 2017; 20(4):490-497. PubMed ID: 28039046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.